quant Healthcare Fund - Growth Option - Regular Plan
Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 11-07-2023
AUM:
₹ 279.47 Cr
Expense Ratio
2.37%
Benchmark
S&P BSE Healthcare TRI
ISIN
INF966L01CG3
Minimum Investment
5000.0
Minimum Topup
1000.0
Minimum SIP Amount
Fund Manager
Sanjeev Sharma, Vasav Sahgal, Sandeep Tandon, Ankit A Pande
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| quant Healthcare Fund - Growth Option - Regular Plan | - | - | - |
| S&P BSE Healthcare TRI | 52.62 | 13.64 | 22.27 |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
13.5188
Last change
0.19 (1.4417%)
Fund Size (AUM)
₹ 279.47 Cr
Performance
35.11% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The scheme seeks to long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.
Fund Manager
Sanjeev Sharma, Vasav Sahgal, Sandeep Tandon, Ankit A Pande
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| Reliance Industries Ltd. | 9.38 |
| Aurobindo Pharma Ltd. | 9.22 |
| Poly Medicure Ltd. | 8.75 |
| Life Insurance Corporation of India | 8.58 |
| Glaxosmithkline Pharmaceuticals Ltd. | 7.91 |
| Indraprastha Medical Corporation Ltd. | 6.41 |
| Jubilant Pharmova Ltd. | 6.03 |
| Kovai Medical Center & Hospital Ltd. | 5.9 |
| Gujarat Themis Biosyn Ltd. | 4.77 |
| Dishman Carbogen Amcis Ltd. | 4.65 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 77.97 |
| Energy | 9.38 |
| Insurance | 8.58 |
| Services | 2.95 |
| Financial | 1.79 |
| N/A | 0.02 |
| Others | -0.69 |
Peer Comparison
| Scheme Name | 5Y (%) |
|---|---|
| quant Healthcare Fund Reg Gr | 0.0 |
| ICICI Pru Pharma Healthcare and Diagnostics PHD Fund Cum | 25.77 |
| ABSL Pharma and Healthcare Reg Gr | 0.0 |
| Tata India Pharma & Healthcare Reg Gr | 23.56 |
| SBI HEALTHCARE Opportunities Reg Gr | 24.87 |
| Nippon India Pharma Fund Gr Gr | 24.41 |
| UTI Healthcare Reg Gr | 22.44 |
| DSP Healthcare Reg Gr | 27.19 |
| Mirae Asset Healthcare Reg Gr | 25.04 |
| LIC MF Healthcare Fund Reg Gr | 19.52 |